Patents by Inventor Yves Merieux

Yves Merieux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8563704
    Abstract: The present invention relates to a peptide aptamer which mimics particularly the human platelet antigen HPA-Ia epitope present on the platelet GPIIb/IIIa molecules and which is capable of neutralizing the binding of HPA-I a specific antibodies (anti-HPA-1 a). This peptide aptamer is advantageously used in a method for detecting and identifying HPA-I a specific antibodies in human serum, in a diagnostic kit for screening and identifying antibodies, in an immunoassay and a pharmaceutical composition.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: October 22, 2013
    Assignee: Stiftung für Diagnostische Forschung
    Inventors: Dominique Rigal, Julien Thibaut, Gemain Gillet, Yves Merieux
  • Publication number: 20120245338
    Abstract: The present invention relates to a peptide aptamer which mimics particularly the human platelet antigen HPA-Ia epitope present on the platelet GPIIb/IIIa molecules and which is capable of neutralizing the binding of HPA-I a specific antibodies (anti-HPA-1 a). This peptide aptamer is advantageously used in a method for detecting and identifying HPA-I a specific antibodies in human serum, in a diagnostic kit for screening and identifying antibodies, in an immunoassay and a pharmaceutical composition.
    Type: Application
    Filed: April 18, 2012
    Publication date: September 27, 2012
    Applicant: STIFTUNG FUR DIAGNOSTISCHE FORSCHUNG
    Inventors: Dominique Rigal, Julien Thibaut, Gemain Gillet, Yves Merieux
  • Patent number: 8183055
    Abstract: The present invention relates to a peptide aptamer which mimics particularly the human platelet antigene HPA-Ia epitope present on the platelet GPIIb/IIIa molecules and which is capable of neutralizing the binding of HPA-I a specific antibodies (anti-HPA-1 a). This peptide aptamer is advantageously used in a method for detecting and identifying HPA-I a specific antibodies in human serum, in a diagnostic kit for screening and identifying antibodies, in an immunoassay and a pharmaceutical composition.
    Type: Grant
    Filed: February 7, 2007
    Date of Patent: May 22, 2012
    Assignee: Stiftung für Diagnostische Forschung
    Inventors: Dominique Rigal, Julien Thibaut, Gemain Gillet, Yves Merieux
  • Patent number: 8080242
    Abstract: The present invention relates to a monoclonal antibody selectively recognizing a human platelet alloantigen, a method for detecting the presence or absence of at least one human platelet alloantigen using said antibody, a method for the production of said antibody, a pharmaceutical composition comprising said antibody, and a kit containing said antibody.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: December 20, 2011
    Assignee: Stiftung Für Diagnostische Forschung
    Inventors: Dominique Rigal, Jean Jacques Pin, Yves Merieux
  • Publication number: 20090318363
    Abstract: The present invention relates to a peptide aptamer which mimics particularly the human platelet antigene HPA-Ia epitope present on the platelet GPIIb/IIIa molecules and which is capable of neutralizing the binding of HPA-I a specific antibodies (anti-HPA-1 a). This peptide aptamer is advantageously used in a method for detecting and identifying HPA-I a specific antibodies in human serum, in a diagnostic kit for screening and identifying antibodies, in an immunoassay and a pharmaceutical composition.
    Type: Application
    Filed: February 7, 2007
    Publication date: December 24, 2009
    Applicant: STIFTUNG FUR DIAGNOSTISCHE FORSCHUNG
    Inventors: Dominique Rigal, Julien Thibaut, Gemain Gillet, Yves Merieux
  • Publication number: 20090117128
    Abstract: The present invention relates to a monoclonal antibody selectively recognizing a human platelet alloantigen, a method for detecting the presence or absence of at least one human platelet alloantigen using said antibody, a method for the production of said antibody, a pharmaceutical composition comprising said antibody, and a kit containing said antibody.
    Type: Application
    Filed: June 13, 2008
    Publication date: May 7, 2009
    Applicant: Stiftung fur Diagnostische
    Inventors: Dominique Rigal, Jean Jacques Pin, Yves Merieux